VenusRoses Labsolutions (VR) is a contract R&D and manufacturing company specializing in innovative nutraceuticals, cosmeceuticals, herbal medicines, and food supplements. VR’s expertise spans novel encapsulation technologies (e.g. “micropellets in oil” for controlled release), in vitro/in vivo/in silicoclinical validation of bioactive compounds (anti-aging, antioxidant, antimicrobial, anti-inflammatory), regulatory affairs & IPR, as well as safety and sustainability assessments (including environmental Life Cycle Assessment and techno-economic analysis). VR has a strong EU project track record (e.g. EXPLORA, INTEGRANO, MET-EFFECT, EthnoHERBS, EXANDAS), demonstrating its capacity in developing eco-friendly extraction, formulation, scale-up and commercialization of plant-derived products. Leveraging this expertise and experience, we have identified a set of Horizon Europe 2026–2027 topics under Cluster 1 (Health) and Cluster 6 (Food, Bioeconomy, Natural Resources, Agriculture & Environment) where VR could be a valuable consortium member or coordinator. Below we present these topics with rationale for alignment to VR’s capabilities and the potential role VR could play in each.
Preventive health via diet/lifestyle; develops herbal supplements & nutraceuticals for metabolic health for community NCD prevention.
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Author
European Affairs at Venus Roses Lab Solutions Ltd.